Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Tofacitinib may help regrow hair in alopecia areata patients.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Tofacitinib helped a patient regrow hair after 40 years of total hair loss.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Tofacitinib helped a man with alopecia totalis regrow all his hair.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

Oral tofacitinib successfully treated total body hair loss in one patient.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Oral betamethasone works faster than oral tofacitinib for hair regrowth in alopecia areata.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

Tapinarof cream at 1% concentration is effective and better tolerated for treating atopic dermatitis than the 2% concentration.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Tofacitinib is effective and safe for treating severe alopecia areata.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Topical tacrolimus is effective and safe for treating alopecia areata.